Genesisbiotech Group


  • Pallai, R., A. Bhaskar, N. Barnett-Bernodat, C. Gallo-Ebert, J. T. Nickels, Jr., and L. M. Rice. 2015. Cancerous inhibitor of protein phosphatase 2A promotes premature chromosome segregation and aneuploidy in prostate cancer cells through association with shugoshin. Tumour Biol 36:6067-6074.
  • Pallai, R., A. Bhaskar, N. Barnett-Bernodat, C. Gallo-Ebert, M. Pusey, J. T. Nickels, Jr., and L. M. Rice. 2015. Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells. Tumour Biol 36:6383-6390 .
  • Wandzioch, E., Pusey, M., Werda A., Bhaskar, A., & Rice, L.M. 2014. High expression of PME-1 in endometrial cancer cells promotes epithelial to mesenchymal transition via enhanced ERK, Akt, and β-catenin phosphorylation. Cancer Research. 2014 Aug 15; 74(16):4295-305.
  • Pusey, M., Bail, S., Werda, A., Rice, L.M. 2014. Protein Phosphatase Methylesterase 1: A potential therapeutic target and companion diagnostic marker for cancer. Cancer Cell & Microenvironment. 20141(5): e299.
  • Huang, L.P., Savoly, D., Sidi, A.A., Adelson, M.E., Mordechai, E. & Trama, J.P. 2012. CIP2A protein expression in high-grade, high-stage bladder cancer. Cancer Med 1, 76-81.
  • Hilbert, D.W., Paulish-Miller, T.E., Tan, C.K., Carey, A.J., Ulett, G.C., Mordechai, E., Adelson, M.E., Gygax, S.E. & Trama, J.P. 2012. Clinical Escherichia coli isolates utilize alpha-hemolysin to inhibit in vitro epithelial cytokine production. Microbes Infect 14, 628-638.
  • Stemmer, S.M., Adelson, M.E., Trama, J.P., Dorak, M.T. & Mordechai, E. 2012. Detection rates of trichomonas vaginalis, in different age groups, using real-time polymerase chain reaction. J Low Genit Tract Dis 16, 352-357.
  • Scher, M.B., Elbaum, M.B., Mogilevkin, Y., Hilbert, D.W., Mydlo, J.H., Sidi, A.A., Adelson, M.E., Mordechai, E. & Trama, J.P. 2012. Detecting DNA methylation of the BCL2, CDKN2A and NID2 genes in urine using a nested methylation specific polymerase chain reaction assay to predict bladder cancer. J Urol 188, 2101-2107.
  • Pallai, R., Bhaskar, A., Sodi, V. & Rice, L.M. 2012. Ets1 and Elk1 transcription factors regulate cancerous inhibitor of protein phosphatase 2A expression in cervical and endometrial carcinoma cells. Transcription 3, 323-335.
  • Datta A, Adelson ME, Mogilevkin Y, Mordechai E, Sidi AA, Trama JP. 2011. Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer. BMC Cancer. 2011 Jun 10; 11: 234.
  • Nolt JK*, Rice LM*, Gallo-Ebert C, Bisher ME, Nickels JT. 2011. PP2ACdc55 is required for multiple events during meiosis I. Cell Cycle. 2011 May 1; 10(9): 1420 – 34. (* These authors contributed equally.).
  • Huang LP, Adelson ME, Mordechai E, Trama JP. 2010. CIP2A expression is elevated in cervical cancer. Cancer Biomark. 2010 – 2011; 8(6): 309 – 17.
  • Martin AG, Trama J, Crighton D, Ryan KM, Fearnhead HO. 2009. Activation of p73 and induction of Noxa by DNA damage requires NK-kappa B. Aging (Albany NY). 2009 Feb 18; 1(3):335-49.
  • Huang LP, Lyu SC, Clayberger C, Krensky AM. 2007. Granulysin-mediated tumor rejection in transgenic mice. J Immunol. 2007 Jan 1; 178(1):77-84.

Latest News

Updated Website! - The Oncoveda website has been fully updated! Please take a moment to learn about our current programs and scientific members!

Projects for Lab Rotations/Internships within Oncoveda - Please access the Research Page (link above) to learn about the lab rotation/internship projects that are currently available in Oncoveda.

Article Accepted into Tumor Biology - Our article further describing the role of PME-1 in endometrial cancer tumor progression titled "Inhibition of Protein Methylesterase 1 decreased cancerous phenotypes in endometrial adenocarcinoma cell lines and xenograft tumor models" has been accepted for publication in Tumor Biology.